159 related articles for article (PubMed ID: 7784348)
1. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.
Balogh G; Csizér E; Ferenczy GG; Halmos Z; Herényi B; Horváth P; Laukó A; Görög S
Pharm Res; 1995 Feb; 12(2):295-8. PubMed ID: 7784348
[TBL] [Abstract][Full Text] [Related]
2. Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.
Görög S; Balogh G; Csehi A; Csizér E; Gazdag M; Halmos Z; Hegedüs B; Herényi B; Horváth P; Laukó A
J Pharm Biomed Anal; 1993; 11(11-12):1219-26. PubMed ID: 8123737
[TBL] [Abstract][Full Text] [Related]
3. Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
Babják M; Balogh G; Gazdag M; Görög S
J Pharm Biomed Anal; 2002 Aug; 29(6):1153-7. PubMed ID: 12110402
[TBL] [Abstract][Full Text] [Related]
4. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
Görög S
Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
[TBL] [Abstract][Full Text] [Related]
5. [Rapid identification of the isomeric impurity in raw drug of cefepime dihydrochloride by liquid chromatography-tandem mass spectrometry].
Zhao L; Guo JF; Zhang AJ; Zhao YM
Yao Xue Xue Bao; 2005 Apr; 40(4):361-4. PubMed ID: 16011268
[TBL] [Abstract][Full Text] [Related]
6. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
[TBL] [Abstract][Full Text] [Related]
7. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high-performance liquid chromatography combined with mass spectrometry.
Xu H; Wang D; Sun C; Pan Y; Zhou M
J Pharm Biomed Anal; 2007 Jun; 44(2):414-20. PubMed ID: 17420108
[TBL] [Abstract][Full Text] [Related]
8. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.
Karthikeyan K; Arularasu GT; Murali V; Pillai KC
J Pharm Biomed Anal; 2011 Jan; 54(1):208-12. PubMed ID: 20727702
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of three potential impurities of pholcodine bulk drug substance.
Denk OM; Gray AI; Skellern GG; Watson DG
J Pharm Pharmacol; 2000 Jul; 52(7):819-29. PubMed ID: 10933132
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of a new impurity in lorazepam substance.
Cepanec I; Mikuldas H; Litvić M; Vukusić I
Pharmazie; 2001 Nov; 56(11):857-9. PubMed ID: 11817169
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
Rao RN; Maurya PK; Raju AN
J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
[TBL] [Abstract][Full Text] [Related]
12. Identification of a new impurity in lisinopril.
Shinde V; Trivedi A; Upadhayay PR; Gupta NL; Kanase DG; Chikate R
J Pharm Biomed Anal; 2007 Jan; 43(1):381-6. PubMed ID: 16926080
[TBL] [Abstract][Full Text] [Related]
13. Estimation of impurity profiles of drugs and related materials Part 15. Identification of minor impurities in cimetidine.
Halmos Z; Szántay C; Brlik J; Csehi A; Varga K; Horváth P; Kislaki M; Domány G; Nemes A; Görög S
J Pharm Biomed Anal; 1996 Oct; 15(1):1-5. PubMed ID: 8895070
[TBL] [Abstract][Full Text] [Related]
14. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
Che F; Lu Y; Xi X; Lan T; Wei Y
Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
[TBL] [Abstract][Full Text] [Related]
15. Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.
Liu C; Yu Z; Wang F; Zhong X; Jiang L; Zhang F; Tang Y; Yan Z; Zeng S; Pu T
J Chromatogr Sci; 2015 Aug; 53(7):1163-8. PubMed ID: 25644811
[TBL] [Abstract][Full Text] [Related]
16. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR.
Baksam V; Nimmakayala S; Devineni SR; Muchumarri RMR; Shandilya S; Kumar P
J Pharm Biomed Anal; 2021 Oct; 205():114297. PubMed ID: 34391137
[TBL] [Abstract][Full Text] [Related]
18. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
19. Separation and identification of some common isomeric plant triterpenoids by thin-layer chromatography and high-performance liquid chromatography.
Martelanc M; Vovk I; Simonovska B
J Chromatogr A; 2009 Sep; 1216(38):6662-70. PubMed ID: 19695573
[TBL] [Abstract][Full Text] [Related]
20. Identification of an isomer impurity in piperaquine drug substance.
Lindegårdh N; Giorgi F; Galletti B; Di Mattia M; Quaglia M; Carnevale D; White NJ; Mazzanti A; Day NP
J Chromatogr A; 2006 Dec; 1135(2):166-9. PubMed ID: 17046006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
